NCT04718428

Brief Summary

This study aims to identify the nail ultrasonography (NUSG) properties in patients with psoriatic arthritis (PsA) and healthy controls by a participant-based evaluation; to assess feasibility, reliability, and discriminative performances; to explore final scorings; and to determine associations between the NUSG scores and participant characteristics, including demographics and disease-related factors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2019

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2020

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 22, 2021

Completed
Last Updated

January 26, 2021

Status Verified

January 1, 2021

Enrollment Period

1.7 years

First QC Date

December 30, 2020

Last Update Submit

January 22, 2021

Conditions

Keywords

nail ultrasonographypsoriatic arthritis

Outcome Measures

Primary Outcomes (5)

  • The nail plate impairment score

    The sonographic normal nail plate term indicates a trilaminar band of the nail plate with two hyperechoic layers separated by a hypoechoic one. The "nail plate impairment score" means the number of nails with impaired trilaminar band (plate) among the 12 nails (all hand nails and toenails). The score ranges between 0-12, with 0 indicating no plate impairments (better) and 12 reflecting the maximal prevalence of impairment (worse).

    Baseline (T0)

  • The nail plate thickness score

    The plate thickness of each nail was measured (in millimeters) by greyscale USG, then, the sum of 12 nails evaluated (all hand nails and toenails) was calculated as "nail plate thickness score" for a participant (in millimeters). Higher scores were expected to mean worse outcome.

    Baseline (T0)

  • The nail bed thickness score

    The sonographic nail bed is the dark area below the nail plate to the cortical bone. The nail bed thickness of each nail was measured (in millimeters) by greyscale USG, then, the sum of 12 nails evaluated (all hand nails and toenails) was calculated as "nail bed thickness score" (in millimeters) for a participant. Higher scores were expected to mean worse outcome.

    Baseline (T0)

  • The nail thickness score

    The total nail thickness (including the plate and bed) of each nail was measured (in millimeters) by greyscale USG, then, the sum of 12 nails evaluated (all hand nails and toenails) was calculated as "nail thickness score" (in millimeters) for a participant. Higher scores were expected to mean worse outcome.

    Baseline (T0)

  • The Doppler activity score

    Doppler activity of the nail bed and matrix was measured by power Doppler USG. The power Doppler signal for each nail was graded from 0 to 3: 1 point for a signal in less than 25 percent of the nail bed area, 2 points for a signal 25 to 50 percent, 3 points for a confluent signal in more than 50 percent of the nail bed area, and 0 point for no signal. Then, the sum of 12 nails evaluated (all hand nails and toenails) was calculated as "Doppler activity score". The score ranges between 0-36, with 0 indicating no activity (better) and 36 reflecting the maximal activity (worse).

    Baseline (T0)

Secondary Outcomes (2)

  • Interobserver reliability of the NUSG scorings

    Baseline (T0)

  • Intraobserver reliability of the NUSG scorings

    Two weeks after the baseline (T1)

Other Outcomes (4)

  • Minimal Disease Activity

    Baseline (T0)

  • Disease Activity index for PSoriatic Arthritis

    Baseline (T0)

  • Psoriasis Area and Severity Index

    Baseline (T0)

  • +1 more other outcomes

Study Arms (2)

psoriatic arthritis

Patients with psoriatic arthritis who met the CASPAR criteria and were 18-70 years old were included. Participants with infection of the nails to be examined, loss of nails, trauma history of the nails, having the habit of nail biting, peripheral neuropathy, peripheral vascular disease, another rheumatological disease, systemic infection, and pregnancy were excluded.

Diagnostic Test: Nail Ultrasonography

healthy controls

A gender- and age-matched healthy controls were included. They were recruited from the healthy relatives of the hospital staff. Participants with infection of the nails to be examined, loss of nails, trauma history of the nails, having the habit of nail biting, peripheral neuropathy, peripheral vascular disease, any rheumatological disease, systemic infection, and pregnancy were excluded.

Diagnostic Test: Nail Ultrasonography

Interventions

Nail UltrasonographyDIAGNOSTIC_TEST

The MyLab 60 (Esaote Biomedica Genoa, Italy) device and linear probe were used. Nails were examined in B-mode grayscale and power Doppler.

healthy controlspsoriatic arthritis

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients met the CASPAR criteria and healthy controls had no inflammatory or mechanical musculoskeletal disease. Participants in the age range of 18-70 were included. The control group was recruited from the healthy relatives of the hospital staff. The PsA group was recruited from Marmara University Physical Medicine and Rehabilitation/Rheumatology clinic.

You may qualify if:

  • Clinical diagnosis of Psoriatic arthritis
  • Healthy controls without any musculoskeletal disease
  • Must be at the age of 18-70 years

You may not qualify if:

  • Infection of the nails to be examined
  • Loss of nails to be examined
  • Trauma history of the nails to be examined
  • Having the habit of nail-biting
  • Peripheral neuropathy
  • Peripheral vascular disease
  • Any rheumatological disease, except psoriatic arthritis
  • Systemic infection
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University

Istanbul, 34899, Turkey (Türkiye)

Location

Related Publications (3)

  • Sandre MK, Rohekar S. Psoriatic arthritis and nail changes: exploring the relationship. Semin Arthritis Rheum. 2014 Oct;44(2):162-9. doi: 10.1016/j.semarthrit.2014.05.002. Epub 2014 May 6.

    PMID: 24932889BACKGROUND
  • Arbault A, Devilliers H, Laroche D, Cayot A, Vabres P, Maillefert JF, Ornetti P. Reliability, validity and feasibility of nail ultrasonography in psoriatic arthritis. Joint Bone Spine. 2016 Oct;83(5):539-44. doi: 10.1016/j.jbspin.2015.11.004. Epub 2015 Dec 10.

    PMID: 26688297BACKGROUND
  • Acer Kasman S, Gezer HH, Baklacioglu HS, Erdem Gursoy D, Duruoz MT. A standardized sonographic analysis of nails in psoriatic arthritis and healthy controls: Feasibility, reliability, diagnostic performance, and demographic and clinical associations. Joint Bone Spine. 2021 Oct;88(5):105197. doi: 10.1016/j.jbspin.2021.105197. Epub 2021 Apr 24.

MeSH Terms

Conditions

Arthritis, Psoriatic

Condition Hierarchy (Ancestors)

SpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesArthritisJoint DiseasesPsoriasisSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Mehmet Tuncay Duruöz, Professor

    Marmara University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2020

First Posted

January 22, 2021

Study Start

October 14, 2017

Primary Completion

June 15, 2019

Study Completion

August 30, 2020

Last Updated

January 26, 2021

Record last verified: 2021-01

Locations